Bcl2l11−/−Faslpr/lpr and even Bcl2l11+/−Faslpr/lpr mice developed lymphadenopathy and splenomegaly at a dramatically increased magnitude and rate compared to mice lacking either apoptosis initiator alone (Figure 4; Figure S5). The gene discussed is BCL2L11; the disease is Lymphadenopathy.